We also noticed that sST2, as opposed to NT-proBNP, is not influenced by certain confounding parameters that could alter its serum levels, such as non-modifiable constitutional aspects (e.g., age, gender), or commonly found conditions in patients with HF (e.g., obesity, renal dysfunction). The gene discussed is NPPB; the disease is obesity disorder.